We further measured the plasma concentration of PDGF-BB, TIMP-1, TIMP-2, ANG-1, CXCL16, and VEGFR2 by ELISA kits in a large cohort, which comprised 115 NPDR and 115 T2DM patients. This evidence concerns the gene CXCL16 and type 2 diabetes mellitus.